HIGHER DIMENSIONS OF HEALING, LLC Ketamine Clinic
725 Basque Way, Suite 3 & 4, Carson City
4.8(22 Google reviews)
United States
1 listed treatment center serving Carson City and the surrounding area.
725 Basque Way, Suite 3 & 4, Carson City
4.8(22 Google reviews)
The cost of Spravato depends on your insurance benefits, the treatment setting, and how services are billed. Both the medication and the visit for administration and observed monitoring may generate charges. Before starting, ask for a written estimate that separates these services and explains your potential out-of-pocket responsibility.
Prior authorization is common. Your insurer may require records of earlier antidepressant trials before reviewing coverage. Ask the treatment center which records it needs, including medication names, doses, treatment dates, and your response or side effects. Your current or previous prescriber may be able to provide this history. Authorization is not a guarantee that every related charge will be paid.
Medicare coverage may fall under Part B or Part D, depending on the plan and treatment setting. Nevada Medicaid coverage also depends on the plan and applicable requirements. Confirm benefits directly rather than assuming a center accepts your coverage or that a covered medication means the monitoring visit is covered.
Manufacturer savings programs exist for some eligible commercially insured patients, but these programs are not for people using government insurance. Ask about current eligibility rules and which charges, if any, a program helps with.
Before scheduling, ask the center and insurer:
This directory currently has no listed treatment center in Carson City. It also has no other Nevada cities with listed centers to suggest here. That is a limitation of the available listings, not proof that treatment is unavailable. Ask your mental health clinician or insurer to help locate a setting, then confirm directly that it is certified through the Spravato REMS program and is accepting patients.
Spravato is not a take-home prescription. You self-administer the nasal spray in a REMS-certified healthcare setting under direct observation. Monitoring continues for at least two hours after each dose, so allow additional time for check-in, preparation, and the clinician's assessment before leaving.
For treatment-resistant depression, the typical labeled schedule starts twice weekly during weeks 1–4, then weekly during weeks 5–8. Maintenance may be weekly or every two weeks. Your prescriber determines the appropriate schedule; do not assume visits will decrease on a fixed timetable.
Arrange for someone else to drive you home after every visit. You must not drive or operate machinery until the next day after a restful sleep. Discuss the center's transportation and discharge requirements before relying on a particular ride arrangement, and have a backup if your driver cancels.
When planning treatment from Carson City:
This directory currently has no listed SPRAVATO® treatment center in Carson City and no other listed Nevada cities to point you toward. Ask your clinician or insurer for help locating a provider. Before scheduling, confirm that the treatment setting is REMS-certified, accepts new patients, and can explain its insurance and transportation requirements.
Spravato is approved for adults with treatment-resistant depression, either alone or with an oral antidepressant. It is also approved for depressive symptoms in adults with major depressive disorder and acute suicidal ideation or behavior, together with an oral antidepressant. It is not approved for children. A clinician must review your history and safety risks to determine whether it is appropriate.
Your location alone does not determine coverage. Benefits depend on your plan, the treatment setting, and authorization requirements. Medicare and Nevada Medicaid may cover treatment in some circumstances, but coverage is not assured. Ask about both medication and monitoring charges, network status, and documentation of earlier antidepressant trials before committing to appointments.
You self-administer the nasal spray under a healthcare provider's direct observation in a REMS-certified setting. The team monitors you for at least two hours after the dose, including for changes in alertness, breathing, and blood pressure. The visit may take longer overall. Arrange a driver home, and do not drive until the next day after a restful sleep.
Important risks include sedation, dissociation—feeling disconnected from yourself or your surroundings—respiratory depression, and increased blood pressure. Spravato also carries boxed warnings about abuse and misuse and suicidal thoughts and behaviors. It is a Schedule III controlled substance. Review your medical history, medications, and substance use history openly with your clinician before treatment.
No. Spravato has not been shown to prevent suicide or reduce suicidal thoughts or behavior, and it does not replace hospitalization when clinically needed. If you are in crisis, call or text 988. If there is immediate danger or a medical emergency, call 911. Do not wait for a treatment consultation or insurance approval to seek urgent help.
Approved uses, nearby treatment centers, and medically sourced patient guides.